# Lancet Oncology Commission on precision oncology equity

> Live situation record from CLSTR: https://clstr.news/situations/lancet-oncology-commission-on-precision-oncology-equity
> Updated: 2026-09-29T07:32:27.000Z. Sources: 8. Developments: 2.

The Lancet Oncology Commission on Cancer Genomics and Precision Oncology has introduced a global roadmap to improve the accessibility, sustainability, and equity of cancer genomics. Presented at the World Cancer Congress in Hong Kong, the initiative addresses the disparity between scientific advancements in molecular information and the actual clinical benefits available to patients worldwide.

The commission highlights that precision oncology, including molecular testing and personalized therapies, remains largely concentrated in wealthy nations and well-equipped medical centers. This creates significant socioeconomic and systemic barriers to care. Furthermore, the commission notes that genomic research and biomarker-driven clinical trials are predominantly centered in high-income countries and Western populations, resulting in fragmented and poorly integrated global data ecosystems.

## Timeline

### 2026-09-29: Lancet Oncology Commission targets equitable access to precision oncology

The Lancet Oncology Commission has released a global roadmap to improve equitable access to cancer genomics and precision oncology, addressing disparities in personalized cancer treatment.

2 sources. https://clstr.news/cluster/lancet-oncology-commission-targets-equitable-access-to-precision-oncology

### 2026-09-25: The Lancet Oncology proposes roadmap to reduce cancer care inequalities

The Lancet Oncology Commission has released a roadmap to address global inequalities in cancer genomics and precision oncology, noting that access to molecular testing remains concentrated in wealthy nations.

6 sources. https://clstr.news/cluster/the-lancet-oncology-proposes-roadmap-to-reduce-cancer-care-inequalities

---
Cite as: Lancet Oncology Commission on precision oncology equity. CLSTR, https://clstr.news/situations/lancet-oncology-commission-on-precision-oncology-equity